SABCS 2012
Interviews and expert commentary from SABCS 2012 — study authors and key opinion leaders discuss the findings and their clinical implications.
Audio Journal of Oncology
Younger than 35 with breast cancer: always consider neoadjuvant chemotherapy
SAN ANTONIO, TEXAS—Women with breast cancer under the age of 35 respond very well to neo-adjuvant chemotherapy as the first line of attack against their disease, according to research from the German
18 December 2012
0:00